Bristol Myers Squibb Co. (BMY)
61.39
+0.82
(+1.35%)
USD |
NYSE |
Oct 29, 16:00
62.39
+1.00
(+1.63%)
Pre-Market: 04:15
Bristol Myers Squibb Total Return Level : 234.66 for Oct. 29, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 29, 2026 | 234.66 |
| October 28, 2026 | 231.52 |
| October 27, 2026 | 235.27 |
| October 26, 2026 | 235.50 |
| October 23, 2026 | 235.00 |
| October 22, 2026 | 240.81 |
| October 21, 2026 | 233.62 |
| October 20, 2026 | 235.77 |
| October 19, 2026 | 224.87 |
| October 16, 2026 | 228.39 |
| October 15, 2026 | 231.52 |
| October 14, 2026 | 226.59 |
| October 13, 2026 | 216.62 |
| October 12, 2026 | 220.09 |
| October 09, 2026 | 225.98 |
| October 08, 2026 | 227.74 |
| October 07, 2026 | 228.20 |
| October 06, 2026 | 227.78 |
| October 05, 2026 | 224.80 |
| October 02, 2026 | 233.74 |
| October 01, 2026 | 232.53 |
| September 30, 2026 | 236.09 |
| September 29, 2026 | 237.83 |
| September 28, 2026 | 241.68 |
| September 25, 2026 | 237.83 |
| Date | Value |
|---|---|
| September 24, 2026 | 232.68 |
| September 23, 2026 | 231.36 |
| September 22, 2026 | 235.52 |
| September 21, 2026 | 236.92 |
| September 18, 2026 | 238.58 |
| September 17, 2026 | 237.75 |
| September 16, 2026 | 240.63 |
| September 15, 2026 | 241.12 |
| September 14, 2026 | 242.52 |
| September 11, 2026 | 240.78 |
| September 10, 2026 | 241.19 |
| September 09, 2026 | 243.69 |
| September 08, 2026 | 244.75 |
| September 04, 2026 | 252.81 |
| September 03, 2026 | 257.61 |
| September 02, 2026 | 255.99 |
| September 01, 2026 | 253.19 |
| August 31, 2026 | 252.77 |
| August 28, 2026 | 251.90 |
| August 27, 2026 | 253.30 |
| August 26, 2026 | 255.65 |
| August 25, 2026 | 256.97 |
| August 24, 2026 | 254.55 |
| August 21, 2026 | 253.53 |
| August 20, 2026 | 247.70 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Johnson & Johnson | 656.68 |
| Eli Lilly & Co. | 3629.60 |
| Merck & Co., Inc. | 452.51 |
| Pfizer Inc. | 100.18 |
| AstraZeneca PLC | 440.21 |